A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer.

被引：0
|
作者：
Sym, Sun Jin
Hong, Junshik
Jung, Minkyu
Park, Jinny
Cho, Eun Kyung
Lee, Jae Hoon
Lee, Won-Suk
Baek, Jeong-Heum
Shin, Dong Bok
机构：
[1] Gachon Univ, Gil Hosp, Dept Internal Med, Inchon, South Korea
[2] Gachon Univ, Gil Hosp, Inchon, South Korea
[3] Gachon Univ, Gil Hosp, Dept Gen Surg, Inchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14137
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
    Zang, D. Y.
    Kim, J. H.
    Hwang, S. W.
    Kim, H. Y.
    Kim, H. J.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Park, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
  • [22] Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
    Shin, Sang Joon
    Jeong, Jae Heon
    Park, Young Suk
    Lee, Kyung Hee
    Shim, Byoung Yong
    Kim, Tae Won
    Oh, Do Youn
    Lee, Myung Ah
    Kim, Yong Tai
    Kim, Yeul Hong
    Zang, Dae Young
    Roh, Jae Kyung
    Ahn, Joong Bae
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1073 - 1080
  • [23] A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer
    Saito, K. O.
    Nakai, Y.
    Isayama, H.
    Ishigaki, K.
    Saito, T.
    Takahara, N.
    Mizuno, S.
    Kogure, H.
    Koike, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [24] Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
    Sang Joon Shin
    Jae Heon Jeong
    Young Suk Park
    Kyung Hee Lee
    Byoung Yong Shim
    Tae Won Kim
    Do Youn Oh
    Myung Ah Lee
    Yong Tai Kim
    Yeul Hong Kim
    Dae Young Zang
    Jae Kyung Roh
    Joong Bae Ahn
    Investigational New Drugs, 2011, 29 : 1073 - 1080
  • [25] A Phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients
    Hsu, Hung-Chih
    Chou, Wen-Chi
    Kuan, Feng-Che
    Lee, Kuan-Der
    Rau, Kun-Ming
    Huang, En-Seng
    Yang, Tsai-Sheng
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6061 - 6070
  • [26] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
    Sun Young Rha
    Yong Hwa Moon
    Hei Chul Jeung
    Yong Tae Kim
    Joo Hyuk Sohn
    Woo Ick Yang
    Chang Ok Suh
    Gwi Eon Kim
    Jae Kyung Roh
    Hyun Cheol Chung
    Breast Cancer Research and Treatment, 2005, 90 : 215 - 221
  • [27] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
    Rha, SU
    Moon, YH
    Jeung, HC
    Kim, YT
    Sohn, JH
    Yang, WI
    Suh, CO
    Kim, GE
    Roh, JK
    Chung, HC
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (03) : 215 - 221
  • [28] Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC)
    Solis Hernandez, Maria Del Pilar
    Jimenez, Paula
    Faez Garcia, Laura
    Alvarez Fernandez, Carlos
    Perez Arnillas, Quionia
    Rodriguez Rubi, David Jose
    Lucrecia Ruiz, Ana
    Sanchez Lorenzo, Luisa
    Li Torres, Walter Antonio
    Uriol, Esther
    Dolores, Maria
    Prieto, Menendez
    Maria Vieitez de Prado, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.
    Gennatas, C
    Mouratidou, D
    Tsavaris, N
    Andreadis, C
    Michalaki, V
    Psychogios, J
    Poulakaki, N
    Gennatas, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 63S - 63S
  • [30] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
12345